1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. T2 BIOSYSTEMS INC
T2 Biosystems Inc XNAS: TTOO

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for T2 Biosystems Inc is on 24 Jun 2025 for the purpose of T2 Biosystems Inc First Quarter Earnings Result for 2025 See details


Insider Trading disclosures for T2 Biosystems Inc

The latest disclosure was made by Laura Adams in T2 Biosystems Inc where a trade of 25,000 Restricted Stock Units done was reported to US exchanges on Nov. 4, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Laura Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 25,000 25,000 - - Restricted Stock Units
Robin Toft Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 25,000 25,000 - - Restricted Stock Units
Ninfa Saunders M. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 25,000 25,000 - - Restricted Stock Units
Seymour Liebman E. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 25,000 25,000 - - Restricted Stock Units
J. John Sperzel Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 490,000 490,000 - - Restricted Stock Units
Giffin Brett A. Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 180,000 180,000 - - Restricted Stock Units
David Elsbree B. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 25,000 25,000 - - Restricted Stock Units
M. John Sprague CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 180,000 180,000 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 190,000 190,000 - - Restricted Stock Units
M. John Sprague CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 180,000 180,000 - - Restricted Stock Units
Gibbs Michael Terrence General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 190,000 190,000 - - Restricted Stock Units
Brett A. Giffin Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 180,000 180,000 - - Restricted Stock Units
John Cumming W. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 35,000 35,000 - - Restricted Stock Units
Sperzel John J. Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2024 490,000 490,000 - - Restricted Stock Units
David B. Elsbree Director Sale of securities on an exchange or to another person at price $ 2.42 per share. 13 Sep 2024 55 23 (0%) 0% 2.4 133 Common Stock
John J. Sperzel Director, See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2024 67 400 (0%) 0% - Common Stock
Terrence Michael Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2024 29 0 - - Restricted Stock Units
M. John Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2024 29 0 - - Restricted Stock Units
Terrence Michael Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2024 29 135 (0%) 0% - Common Stock
John Sprague M. Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2024 29 141 (0%) 0% - Common Stock
John J. Sperzel Director, See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2024 67 0 - - Restricted Stock Units
A. Giffin Brett Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2024 13 13 - - Restricted Stock Units
J. Sperzel John Director, See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 160 333 (0%) 0% - Common Stock
Giffin Brett A. Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 13 77 (0%) 0% - Common Stock
Gibbs Terrence Michael General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 40 40 - - Restricted Stock Units
John Sperzel J. Director, See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 160 160 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 40 106 (0%) 0% - Common Stock
M. John Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 40 112 (0%) 0% - Common Stock
John Sprague M. Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2024 40 40 - - Restricted Stock Units
Toft Robin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 6,369 6,369 - - Restricted Stock Units
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2023 454 0 - - Restricted Stock Units
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2023 454 3,472 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 0.48 per share. 28 Mar 2023 239 6,612 (0%) 0% 0.5 115 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Mar 2023 334 6,851 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Mar 2023 334 0 - - Restricted Stock Units
John J. Sperzel Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 16,000 20,435 (0%) 0% - Common Stock
John J. Sperzel Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 0.59 per share. 20 Feb 2023 2,898 17,329 (0%) 0% 0.6 1,710 Common Stock
John J. Sperzel Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 6,667 6,667 - - Restricted Stock Units
John J. Sperzel Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 0.65 per share. 20 Feb 2023 6,875 13,560 (0%) 0% 0.7 4,469 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 2,914 8,102 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 0.59 per share. 20 Feb 2023 1,585 6,517 (0%) 0% 0.6 935 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 4,000 8,000 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 2,914 2,914 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 4,000 7,333 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 0.65 per share. 20 Feb 2023 2,145 5,188 (0%) 0% 0.6 1,394 Common Stock
John M. Sprague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.65 per share. 20 Feb 2023 1,545 5,502 (0%) 0% 0.6 1,004 Common Stock
John M. Sprague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.59 per share. 20 Feb 2023 1,148 7,268 (0%) 0% 0.6 677 Common Stock
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 4,000 8,000 - - Restricted Stock Units
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 2,914 2,914 - - Restricted Stock Units
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 4,000 7,047 (0%) 0% - Common Stock
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 2,914 8,416 (0%) 0% - Common Stock
Brett A. Giffin Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 1,333 1,378 (0%) 0% - Common Stock
Brett A. Giffin Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 0.65 per share. 20 Feb 2023 537 841 (0%) 0% 0.6 349 Common Stock
Brett A. Giffin Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 1,333 2,667 - - Restricted Stock Units
John J. Sperzel Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 16,000 32,000 - - Restricted Stock Units
John J. Sperzel Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2023 6,667 20,227 (0%) 0% - Common Stock
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 1,550 0 - - Restricted Stock Units
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 1,550 4,568 (0%) 0% - Common Stock
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 454 5,022 (0%) 0% - Common Stock
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 454 0 - - Restricted Stock Units
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 1,550 0 - - Restricted Stock Units
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 454 5,022 (0%) 0% - Common Stock
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 1,550 4,568 (0%) 0% - Common Stock
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 454 0 - - Restricted Stock Units
Brett A. Giffin Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 1.79 per share. 08 Nov 2022 1,292 2,253 (0%) 0% 1.8 2,317 Common Stock
Brett A. Giffin Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Nov 2022 3,333 6,667 - - Restricted Stock Units
Brett A. Giffin Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Nov 2022 3,333 3,545 (0%) 0% - Common Stock
Laura Adams Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Oct 2022 732 732 (0%) 0% - Common Stock
Laura Adams Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Oct 2022 732 1,464 - - Restricted Stock Units
David B. Elsbree Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Oct 2022 115,000 115,000 - - Restricted Stock Units
John W. Cumming Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Oct 2022 130,000 130,000 - - Restricted Stock Units
Seymour E. Liebman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Oct 2022 115,000 115,000 - - Restricted Stock Units
Thierry Bernard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Oct 2022 115,000 115,000 - - Restricted Stock Units
Ninfa M. Saunders Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Oct 2022 115,000 115,000 - - Restricted Stock Units
Robin Toft Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Oct 2022 115,000 115,000 - - Restricted Stock Units
Laura Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Oct 2022 115,000 115,000 - - Restricted Stock Units
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2022 22,727 22,727 - - Restricted Stock Units
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2022 22,727 150,936 (0%) 0% - Common Stock
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2022 22,727 150,936 (0%) 0% - Common Stock
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2022 22,727 22,727 - - Restricted Stock Units
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2022 22,727 150,936 (0%) 0% - Common Stock
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2022 22,727 22,727 - - Restricted Stock Units
David B. Elsbree Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 0 - - Restricted Stock Units
David B. Elsbree Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 276,205 (0%) 0% - Common Stock
John W. Cumming Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 81,967 132,819 (0%) 0% - Common Stock
John W. Cumming Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 81,967 0 - - Restricted Stock Units
Seymour E. Liebman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 235,121 (0%) 0% - Common Stock
Seymour E. Liebman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 0 - - Restricted Stock Units
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 128,209 (0%) 0% - Common Stock
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 0 - - Restricted Stock Units
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 0 - - Restricted Stock Units
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 128,209 (0%) 0% - Common Stock
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 0 - - Restricted Stock Units
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2022 73,224 128,209 (0%) 0% - Common Stock
John M. Sprague Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.48 per share. 08 Apr 2022 10,000 152,350 (0%) 0% 0.5 4,767 Common Stock
Alec Barclay Chief Operations Officer Purchase of securities on an exchange or from another person at price $ 0.50 per share. 08 Apr 2022 12,951 181,944 (0%) 0% 0.5 6,476 Common Stock
Brett A. Giffin Chief Commercial Officer Purchase of securities on an exchange or from another person at price $ 0.49 per share. 08 Apr 2022 10,600 10,600 (0%) 0% 0.5 5,183 Common Stock
John J. Sperzel Director, Chairman, CEO, and President Purchase of securities on an exchange or from another person at price $ 0.50 per share. 07 Apr 2022 30,000 221,773 (0%) 0% 0.5 15,000 Common Stock
Michael Terrence Gibbs General Counsel Purchase of securities on an exchange or from another person at price $ 0.49 per share. 07 Apr 2022 10,000 166,651 (0%) 0% 0.5 4,900 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Mar 2022 16,666 16,667 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Mar 2022 16,666 165,441 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. 24 Mar 2022 8,790 156,651 (0%) 0% 0.4 3,876 Common Stock
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2022 21,666 21,667 - - Restricted Stock Units
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2022 21,666 180,421 (0%) 0% - Common Stock
Alec Barclay Chief Operations Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. 14 Mar 2022 11,428 168,993 (0%) 0% 0.4 4,160 Common Stock
Brett A. Giffin Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2022 500,000 500,000 - - Restricted Stock Units
John J. Sperzel Director, See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2022 333,333 333,333 (0%) 0% - Common Stock
John J. Sperzel Director, See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2022 333,333 666,667 - - Restricted Stock Units
John J. Sperzel Director, See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.45 per share. 24 Feb 2022 141,560 191,773 (0%) 0% 0.4 63,532 Common Stock
Michael Terrence Gibbs General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.45 per share. 24 Feb 2022 76,867 148,775 (0%) 0% 0.4 34,498 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2022 145,719 291,439 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2022 145,719 225,642 (0%) 0% - Common Stock
John M. Sprague Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.45 per share. 24 Feb 2022 55,008 142,350 (0%) 0% 0.4 24,688 Common Stock
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2022 145,719 197,358 (0%) 0% - Common Stock
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2022 145,719 291,439 - - Restricted Stock Units
Alec Barclay Chief Operations Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.45 per share. 24 Feb 2022 88,878 158,755 (0%) 0% 0.4 39,888 Common Stock
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2022 168,488 336,976 - - Restricted Stock Units
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2022 168,488 247,633 (0%) 0% - Common Stock
John J. Sperzel Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2022 2,400,000 2,400,000 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2022 10,000 0 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2022 10,000 85,198 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. 20 Feb 2022 5,275 79,923 (0%) 0% 0.5 2,458 Common Stock
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2022 600,000 600,000 - - Restricted Stock Units
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2022 10,000 0 - - Restricted Stock Units
John M. Sprague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2022 600,000 600,000 - - Restricted Stock Units
John M. Sprague Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. 20 Feb 2022 3,775 51,639 (0%) 0% 0.5 1,759 Common Stock
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2022 10,000 55,414 (0%) 0% - Common Stock
Alec Barclay Chief Operations Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. 20 Feb 2022 5,275 79,145 (0%) 0% 0.5 2,458 Common Stock
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2022 10,000 0 - - Restricted Stock Units
Alec Barclay Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2022 600,000 600,000 - - Restricted Stock Units
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2022 10,000 84,420 (0%) 0% - Common Stock
Aparna Ahuja Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2022 600,000 600,000 - - Restricted Stock Units
Brett A. Giffin Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2022 200,000 200,000 - - Restricted Stock Units
Aparna Ahuja Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.48 per share. 06 Jan 2022 61,988 107,611 (0%) 0% 0.5 29,754 Common Stock
Aparna Ahuja Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2022 153,664 169,599 (0%) 0% - Common Stock
Aparna Ahuja Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2022 153,664 307,328 - - Restricted Stock Units
David B. Elsbree Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 202,981 (0%) 0% - Common Stock
David B. Elsbree Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 0 - - Restricted Stock Units
Seymour E. Liebman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 77,519 77,519 - - Restricted Stock Units
Seymour E. Liebman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 161,897 (0%) 0% - Common Stock
Seymour E. Liebman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 0 - - Restricted Stock Units
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 54,985 (0%) 0% - Common Stock
Thierry Bernard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 77,519 77,519 - - Restricted Stock Units
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 0 - - Restricted Stock Units
Ninfa M. Saunders Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 77,519 77,519 - - Restricted Stock Units
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 0 - - Restricted Stock Units
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 0 - - Restricted Stock Units
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 54,985 (0%) 0% - Common Stock
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 32,258 54,985 (0%) 0% - Common Stock
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2021 22,727 22,727 (0%) 0% - Common Stock
Thierry Bernard Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2021 22,727 45,454 - - Restricted Stock Units
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2021 22,727 45,454 - - Restricted Stock Units
Ninfa M. Saunders Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2021 22,727 22,727 (0%) 0% - Common Stock
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2021 22,727 22,727 (0%) 0% - Common Stock
Robin Toft Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2021 22,727 45,454 - - Restricted Stock Units
John W. Cumming Director Sale of securities on an exchange or to another person at price $ 1.16 per share. 01 Jul 2021 18,182 50,852 (0%) 0% 1.2 21,091 Common Stock
John McDonough Director Sale of securities on an exchange or to another person at price $ 1.16 per share. 01 Jul 2021 18,182 516,386 (1%) 0% 1.2 21,091 Common Stock
David B. Elsbree Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 73,224 73,224 - - Restricted Stock Units
David B. Elsbree Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2021 45,454 170,723 (0%) 0% - Common Stock
David B. Elsbree Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2021 45,454 45,454 - - Restricted Stock Units
John W. Cumming Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2021 45,454 69,034 (0%) 0% - Common Stock
John W. Cumming Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 81,967 81,967 - - Restricted Stock Units
John W. Cumming Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2021 45,454 45,454 - - Restricted Stock Units
Seymour E. Liebman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 73,224 73,224 - - Restricted Stock Units
Seymour E. Liebman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2021 45,454 45,454 - - Restricted Stock Units
Seymour E. Liebman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2021 45,454 129,639 (0%) 0% - Common Stock
John McDonough Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 81,967 81,967 - - Restricted Stock Units
John McDonough Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2021 45,454 534,568 (1%) 0% - Common Stock
John McDonough Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2021 45,454 45,454 - - Restricted Stock Units
Thierry Bernard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 73,224 73,224 - - Restricted Stock Units
Ninfa M. Saunders Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 73,224 73,224 - - Restricted Stock Units
Robin Toft Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 73,224 73,224 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Mar 2021 16,667 33,333 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 1.56 per share. 24 Mar 2021 8,758 73,256 (0%) 0% 1.6 13,662 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Mar 2021 16,667 82,014 (0%) 0% - Common Stock
Anthony Pare Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 1.84 per share. 17 Mar 2021 9,620 31,612 (0%) 0% 1.8 17,701 Common Stock
Alec Barclay Chief Operations Officer Sale of securities on an exchange or to another person at price $ 1.86 per share. 17 Mar 2021 12,494 74,420 (0%) 0% 1.9 23,239 Common Stock
Anthony Pare Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2021 17,500 35,000 - - Restricted Stock Units
Anthony Pare Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2021 17,500 41,232 (0%) 0% - Common Stock
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2021 21,667 43,333 - - Restricted Stock Units
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2021 21,667 86,914 (0%) 0% - Common Stock
Anthony Pare Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2021 505,464 505,464 - - Restricted Stock Units
John J. Sperzel Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2021 1,000,000 1,000,000 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2021 437,158 437,158 - - Restricted Stock Units
John M. Sprague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2021 437,158 437,158 - - Restricted Stock Units
Alec Barclay Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2021 505,464 505,464 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2021 10,000 72,627 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2021 10,000 10,000 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 2.06 per share. 21 Feb 2021 7,280 65,347 (0%) 0% 2.1 14,997 Common Stock
John M. Sprague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 2.04 per share. 21 Feb 2021 5,250 35,485 (0%) 0% 2.0 10,710 Common Stock
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2021 10,000 10,000 - - Restricted Stock Units
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2021 10,000 40,735 (0%) 0% - Common Stock
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2021 10,000 72,527 (0%) 0% - Common Stock
Alec Barclay Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2021 10,000 10,000 - - Restricted Stock Units
Alec Barclay Chief Operations Officer Sale of securities on an exchange or to another person at price $ 2.06 per share. 21 Feb 2021 7,280 65,247 (0%) 0% 2.1 14,997 Common Stock
Aparna Ahuja Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 460,992 460,992 - - Restricted Stock Units
David B. Elsbree Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2021 34,188 125,269 (0%) 0% - Common Stock
David B. Elsbree Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2021 34,188 34,188 - - Restricted Stock Units
David B. Elsbree Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2021 32,258 32,258 - - Restricted Stock Units
Seymour E. Liebman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2021 34,188 34,188 - - Restricted Stock Units
Seymour E. Liebman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2021 32,258 32,258 - - Restricted Stock Units
Seymour E. Liebman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2021 34,188 84,185 (0%) 0% - Common Stock
Thierry Bernard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2021 32,258 32,258 - - Restricted Stock Units
Ninfa M. Saunders Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2021 32,258 32,258 - - Restricted Stock Units
Robin Toft Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2021 32,258 32,258 - - Restricted Stock Units
David B. Elsbree None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2020 45,454 45,454 - - Restricted Stock Units
John W. Cumming None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2020 45,454 45,454 - - Restricted Stock Units
Seymour E. Liebman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2020 45,454 45,454 - - Restricted Stock Units
John McDonough None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2020 45,454 45,454 - - Restricted Stock Units
Thierry Bernard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2020 68,181 68,181 - - Restricted Stock Units
Ninfa Saunders None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2020 68,181 68,181 - - Restricted Stock Units
Robin Toft None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2020 68,181 68,181 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2020 100,000 100,000 - - Stock Option (Right to Buy)
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2020 50,000 50,000 - - Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2020 90,000 90,000 - - Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2020 180,000 180,000 - - Stock Option (Right to Buy)
Alec Barclay SVP, Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2020 130,000 130,000 - - Stock Option (Right to Buy)
Alec Barclay SVP, Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2020 65,000 65,000 - - Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2020 10,000 74,802 (0%) 0% - Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2020 10,000 20,000 - - Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.82 per share. 21 Feb 2020 5,808 68,994 (0%) 0% 0.8 4,763 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2020 10,000 66,587 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2020 10,000 20,000 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 0.82 per share. 21 Feb 2020 5,808 60,779 (0%) 0% 0.8 4,763 Common Stock
John M. Sprague Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.82 per share. 21 Feb 2020 4,166 22,222 (0%) 0% 0.8 3,416 Common Stock
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2020 10,000 26,388 (0%) 0% - Common Stock
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2020 10,000 20,000 - - Restricted Stock Units
Alec Barclay SVP, Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2020 10,000 52,102 (0%) 0% - Common Stock
Alec Barclay SVP, Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2020 10,000 20,000 - - Restricted Stock Units
Alec Barclay SVP, Operations Sale of securities on an exchange or to another person at price $ 0.82 per share. 21 Feb 2020 5,808 46,294 (0%) 0% 0.8 4,763 Common Stock
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.77 per share. 09 Feb 2020 3,200 64,802 (0%) 0% 0.8 2,464 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2020 5,833 68,002 (0%) 0% - Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2020 5,833 0 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2020 5,833 0 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2020 5,833 59,787 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 0.77 per share. 09 Feb 2020 3,200 56,587 (0%) 0% 0.8 2,464 Common Stock
John McDonough None Sale of securities on an exchange or to another person at price $ 1.15 per share. 23 Jan 2020 57,417 512,868 (1%) 0% 1.2 66,030 Common Stock
John McDonough None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2020 100,000 570,285 (1%) 0% - Common Stock
John McDonough None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2020 100,000 0 - - Restricted Stock Units
John McDonough None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2020 16,666 0 - - Restricted Stock Units
John McDonough None Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2020 326,087 0 - - Performance Restricted Stock Units
John McDonough None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2020 16,666 470,285 (0%) 0% - Common Stock
David B. Elsbree None Sale of securities on an exchange or to another person at price $ 1.16 per share. 03 Jan 2020 5,316 91,081 (0%) 0% 1.2 6,167 Common Stock
Adrian M. Jones None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 34,188 4,270,641 (8%) 0% 0 Common Stock
David B. Elsbree None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2020 13,289 13,289 - - Restricted Stock Units
David B. Elsbree None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2020 34,188 34,188 - - Restricted Stock Units
David B. Elsbree None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2020 13,289 96,397 (0%) 0% - Common Stock
Seymour E. Liebman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2020 13,289 13,289 - - Restricted Stock Units
Seymour E. Liebman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2020 34,188 34,188 - - Restricted Stock Units
Seymour E. Liebman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2020 13,289 50 (0%) 0% - Common Stock
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Sep 2019 100,000 100,000 - - Stock Option (Right to Buy)
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Sep 2019 50,000 50,000 - - Stock Option (Right to Buy)
John M. Sprague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Sep 2019 50,000 50,000 - - Stock Option (Right to Buy)
Alec Barclay SVP, Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Sep 2019 200,000 200,000 - - Stock Option (Right to Buy)
Alec Barclay SVP, Operations Sale of securities on an exchange or to another person at price $ 2.92 per share. 10 Sep 2019 4,210 42,102 (0%) 0% 2.9 12,293 Common Stock
Alec Barclay SVP, Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Sep 2019 10,000 46,312 (0%) 0% - Common Stock
David B. Elsbree None Sale of securities on an exchange or to another person at price $ 1.44 per share. 11 Jun 2019 3,600 83,108 (0%) 0% 1.4 5,184 Common Stock
John W. Cumming None Sale of securities on an exchange or to another person at price $ 1.43 per share. 11 Jun 2019 3,420 23,580 (0%) 0% 1.4 4,891 Common Stock
Stanley N. Lapidus None Sale of securities on an exchange or to another person at price $ 1.44 per share. 11 Jun 2019 9,000 53,010 (0%) 0% 1.4 12,960 Common Stock
Michael J. Cima None Sale of securities on an exchange or to another person at price $ 1.43 per share. 11 Jun 2019 3,240 213,178 (0%) 0% 1.4 4,633 Common Stock
David B. Elsbree None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 9,000 - - Restricted Stock Units
David B. Elsbree None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 86,708 (0%) 0% - Common Stock
David B. Elsbree None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2019 22,000 22,000 - - Stock Option (Right to Buy)
John W. Cumming None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 27,000 (0%) 0% - Common Stock
John W. Cumming None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2019 22,000 22,000 - - Stock Option (Right to Buy)
John W. Cumming None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 9,000 - - Restricted Stock Units
Seymour E. Liebman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 9,000 - - Restricted Stock Units
Seymour E. Liebman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2019 22,000 22,000 - - Stock Option (Right to Buy)
Seymour E. Liebman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 36,708 (0%) 0% - Common Stock
Stanley N. Lapidus None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2019 22,000 22,000 - - Stock Option (Right to Buy)
Stanley N. Lapidus None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 9,000 - - Restricted Stock Units
Stanley N. Lapidus None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 62,010 (0%) 0% - Common Stock
Adrian M. Jones None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2019 22,000 22,000 - - Stock Option (Right to Buy)
Michael J. Cima None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 9,000 - - Restricted Stock Units
Michael J. Cima None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2019 9,000 216,418 (0%) 0% - Common Stock
Michael J. Cima None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2019 22,000 22,000 - - Stock Option (Right to Buy)
John McDonough Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 100,000 100,000 - - Restricted Stock Units
John McDonough Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 200,000 200,000 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 30,000 30,000 - - Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 60,000 60,000 - - Stock Option (Right to Buy)
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 60,000 60,000 - - Stock Option (Right to Buy)
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 30,000 30,000 - - Restricted Stock Units
John M. Sprague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 60,000 60,000 - - Stock Option (Right to Buy)
John M. Sprague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 30,000 30,000 - - Restricted Stock Units
Alec Barclay SVP, Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 30,000 30,000 - - Restricted Stock Units
Alec Barclay SVP, Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2019 60,000 60,000 - - Stock Option (Right to Buy)
John McDonough Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2019 16,666 456,354 (0%) 0% - Common Stock
John McDonough Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2019 16,666 16,667 - - Restricted Stock Units
John McDonough Director, President & CEO Sale of securities on an exchange or to another person at price $ 3.36 per share. 09 Feb 2019 8,134 448,220 (0%) 0% 3.4 27,330 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2019 5,834 5,833 - - Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.36 per share. 09 Feb 2019 3,005 69,704 (0%) 0% 3.4 10,097 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2019 5,834 72,709 (0%) 0% - Common Stock
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 3.36 per share. 09 Feb 2019 3,005 57,237 (0%) 0% 3.4 10,097 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2019 5,834 5,833 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2019 5,834 60,262 (0%) 0% - Common Stock
David B. Elsbree None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2019 13,289 13,289 - - Restricted Stock Units
David B. Elsbree None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2019 9,708 9,708 - - Restricted Stock Units
David B. Elsbree None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2019 9,708 77,708 (0%) 0% - Common Stock
Seymour E. Liebman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2019 13,289 13,289 - - Restricted Stock Units
Seymour E. Liebman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2019 9,708 27,708 (0%) 0% - Common Stock
Seymour E. Liebman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2019 9,708 9,708 - - Restricted Stock Units
Adrian M. Jones None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2019 13,289 4,236,453 (8%) 0% 0 Common Stock
Stanley N. Lapidus None Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 06 Nov 2018 27,058 59,058 (0%) 0% 1.2 31,387 Common Stock
Stanley N. Lapidus None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Nov 2018 27,058 0 - - Stock Option (Right to Buy)
Stanley N. Lapidus None Sale of securities on an exchange or to another person at price $ 5.29 per share. 06 Nov 2018 6,048 53,010 (0%) 0% 5.3 31,994 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. 20 Sep 2018 16,602 91,431 (0%) 0% 3.2 53,458 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2018 31,603 0 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.18 per share. 20 Sep 2018 48,205 43,226 (0%) 0% 6.2 297,907 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. 20 Sep 2018 31,603 74,829 (0%) 0% 3.2 101,762 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2018 16,602 0 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.31 per share. 18 Sep 2018 18,588 76,461 (0%) 0% 1.3 24,350 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 18 Sep 2018 14,647 57,873 (0%) 0% 1.2 16,991 Common Stock
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.14 per share. 18 Sep 2018 14,647 128,821 (0%) 0% 6.1 89,933 Common Stock
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.20 per share. 18 Sep 2018 37,902 43,226 (0%) 0% 6.2 234,992 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. 18 Sep 2018 27,499 81,128 (0%) 0% 3.2 88,547 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. 18 Sep 2018 10,403 53,629 (0%) 0% 2.3 23,407 Common Stock
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.17 per share. 18 Sep 2018 85,595 43,226 (0%) 0% 6.2 528,121 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. 18 Sep 2018 1,361 143,468 (0%) 0% 2.2 3,062 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.45 per share. 18 Sep 2018 36,235 142,107 (0%) 0% 2.5 88,776 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.96 per share. 18 Sep 2018 29,411 105,872 (0%) 0% 2.0 57,646 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2018 14,647 0 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2018 18,588 0 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2018 29,411 0 - - (Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2018 36,235 0 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2018 1,361 10,403 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2018 10,403 0 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Sep 2018 27,499 31,603 - - Stock Option (Right to Buy)
Alec Barclay SVP, Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.49 per share. 11 Sep 2018 3,522 33,633 (0%) 0% 6.5 22,858 Common Stock
Alec Barclay SVP, Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2018 10,000 37,155 (0%) 0% 0 Common Stock
Alec Barclay SVP, Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2018 10,000 10,000 - - Restricted Stock Unit
John McDonough Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.72 per share. 20 Jul 2018 35,295 358,614 (0%) 0% 6.7 237,182 Common Stock
Thomas J. Lowery Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.72 per share. 20 Jul 2018 8,721 43,226 (0%) 0% 6.7 58,605 Common Stock
Michael Terrence Gibbs General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.72 per share. 20 Jul 2018 7,824 42,967 (0%) 0% 6.7 52,577 Common Stock
John M. Sprague Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.72 per share. 20 Jul 2018 5,619 11,673 (0%) 0% 6.7 37,760 Common Stock
Alec Barclay See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.72 per share. 20 Jul 2018 7,824 27,155 (0%) 0% 6.7 52,577 Common Stock
John McDonough Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2018 108,696 393,909 (0%) 0% 0 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2018 26,847 51,947 (0%) 0% 0 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2018 24,086 50,791 (0%) 0% 0 Common Stock
John M. Sprague Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2018 17,292 17,292 (0%) 0% 0 Common Stock
Alec Barclay See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2018 24,086 34,979 (0%) 0% 0 Common Stock
David B. Elsbree None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2018 9,000 9,000 - - Restricted Stock Units
John W. Cumming None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2018 9,000 9,000 - - Restricted Stock Units
Seymour E. Liebman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2018 9,000 9,000 - - Restricted Stock Units
Stanley N. Lapidus None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2018 9,000 9,000 - - Restricted Stock Units
Michael J. Cima None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2018 9,000 9,000 - - Restricted Stock Units
Adrian M. Jones None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2018 9,000 4,224,894 (9%) 0% 0 Common Stock
Alec Barclay SVP, Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.53 per share. 06 Jun 2018 4,408 10,893 (0%) 0% 8.5 37,600 Common Stock
Alec Barclay SVP, Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2018 13,583 15,301 (0%) 0% 0 Common Stock
John W. Cumming None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2018 18,000 18,000 (0%) 0% 0 Common Stock
John W. Cumming None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2018 18,000 18,000 - - Restricted Stock Units
Seymour E. Liebman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2018 18,000 18,000 - - Restricted Stock Units
Seymour E. Liebman None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2018 18,000 18,000 (0%) 0% 0 Common Stock
Stanley N. Lapidus None Sale of securities on an exchange or to another person at price $ 8.87 per share. 02 Jun 2018 6,000 32,000 (0%) 0% 8.9 53,220 Common Stock
Stanley N. Lapidus None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2018 18,000 18,000 - - Restricted Stock Units
Stanley N. Lapidus None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2018 18,000 38,000 (0%) 0% 0 Common Stock
Michael J. Cima None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2018 18,000 18,000 - - Restricted Stock Units
Michael J. Cima None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2018 18,000 207,418 (0%) 0% 0 Common Stock
David B. Elsbree None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2018 18,000 68,000 (0%) 0% 0 Common Stock
David B. Elsbree None Purchase of securities on an exchange or from another person at price $ 7.65 per share. 01 Jun 2018 4,225 10,000 (0%) 0% 7.6 32,321 Common Stock
David B. Elsbree None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2018 18,000 18,000 - - Restricted Stock Units
John McDonough Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2018 434,783 434,783 - - Performance Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2018 107,386 107,386 - - Performance Restricted Stock Units
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2018 96,344 96,344 - - Performance Restricted Stock Units
John M. Sprague CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2018 69,170 69,170 - - Performance Restricted Stock Units
Alec Barclay SVP, Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2018 96,344 96,344 - - Performance Restricted Stock Units
John McDonough Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 300,000 300,000 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 90,000 90,000 - - Stock Option (Right to Buy)
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 90,000 90,000 - - Stock Option (Right to Buy)
John M. Sprague Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 225,000 225,000 - - Stock Option (Right to Buy)
John McDonough Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2018 33,130 295,964 (0%) 0% 0 Common Stock
John McDonough Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.53 per share. 09 Feb 2018 10,751 285,213 (0%) 0% 8.5 91,706 Common Stock
John McDonough Director, President & CEO Sale of securities on an exchange or to another person at price $ 4.28 per share. 09 Feb 2018 6,292 262,834 (0%) 0% 4.3 26,930 Common Stock
Thomas J. Lowery Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.53 per share. 09 Feb 2018 5,312 25,100 (0%) 0% 8.5 45,311 Common Stock
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2018 16,370 30,412 (0%) 0% 0 Common Stock
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 4.28 per share. 09 Feb 2018 2,202 14,042 (0%) 0% 4.3 9,425 Common Stock
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 4.28 per share. 09 Feb 2018 2,202 16,911 (0%) 0% 4.3 9,425 Common Stock
Michael Terrence Gibbs General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.53 per share. 09 Feb 2018 4,705 26,705 (0%) 0% 8.5 40,134 Common Stock
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2018 14,499 31,410 (0%) 0% 0 Common Stock
David B. Elsbree None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2018 9,708 9,708 - - Restricted Stock Units
Seymour E. Liebman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2018 9,708 9,708 - - Restricted Stock Units
Adrian M. Jones None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2017 9,708 4,214,164 (11%) 0% 0 Common Stock
John McDonough Director, President & CEO Sale of securities on an exchange or to another person at price $ 3.35 per share. 30 Nov 2017 4,895 449,131 (1%) 0% 3.3 16,398 Common Stock
John McDonough Director, President & CEO Sale of securities on an exchange or to another person at price $ 3.47 per share. 30 Nov 2017 9,443 439,688 (0%) 0% 3.5 32,767 Common Stock
John McDonough Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 47,423 0 - - Restricted Stock Units
John McDonough Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 47,422 0 - - Restricted Stock Units
John McDonough Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 47,423 406,604 (1%) 0% 0 Common Stock
John McDonough Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 47,422 454,026 (1%) 0% 0 Common Stock
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.35 per share. 30 Nov 2017 2,166 71,060 (0%) 0% 3.3 7,256 Common Stock
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.47 per share. 30 Nov 2017 4,185 66,875 (0%) 0% 3.5 14,522 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 15,000 0 - - Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 15,000 0 - - Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 15,000 58,226 (0%) 0% 0 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 15,000 73,226 (0%) 0% 0 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 6,500 50,687 (0%) 0% 0 Common Stock
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 3.47 per share. 30 Nov 2017 1,820 54,428 (0%) 0% 3.5 6,315 Common Stock
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 6,500 0 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 6,500 0 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2017 6,500 57,187 (0%) 0% 0 Common Stock
Michael Terrence Gibbs General Counsel Sale of securities on an exchange or to another person at price $ 3.35 per share. 30 Nov 2017 939 56,248 (0%) 0% 3.4 3,146 Common Stock
David B. Elsbree None Purchase of securities on an exchange or from another person at price $ 4.11 per share. 16 Nov 2017 1,500 5,775 (0%) 0% 4.1 6,165 Common Stock
Darlene M. Deptula-Hicks SVP & Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.58 per share. 06 Jun 2017 4,000 4,000 (0%) 0% 3.6 14,320 Common Stock
David B. Elsbree None Purchase of securities on an exchange or from another person at price $ 3.50 per share. 06 Jun 2017 10,000 50,000 (0%) 0% 3.5 35,000 Common Stock
Stanley N. Lapidus None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2017 20,000 27,058 - - Stock Option (Right to Buy)
Stanley N. Lapidus None Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 06 Jun 2017 20,000 20,000 (0%) 0% 1.2 23,200 Common Stock
John McDonough Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2017 11,729 0 - - Stock Option (Right to Buy)
John McDonough Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.96 per share. 06 Jun 2017 21,465 247,353 (0%) 0% 2.0 42,071 Common Stock
John McDonough Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 06 Jun 2017 11,729 225,888 (0%) 0% 1.2 13,606 Common Stock
John McDonough Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 06 Jun 2017 16,806 214,159 (0%) 0% 1.2 19,495 Common Stock
John McDonough Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2017 21,465 106,025 - - Stock Option (Right to Buy)
John McDonough Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2017 16,806 0 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. 06 Jun 2017 4,000 10,411 (0%) 0% 1.2 4,640 Common Stock
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2017 4,000 14,647 - - Stock Option (Right to Buy)
Michael J. Cima None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2017 5,000 53,823 - - Stock Option (Right to Buy)
Michael J. Cima None Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.96 per share. 06 Jun 2017 5,000 189,418 (0%) 0% 2.0 9,800 Common Stock
Michael Terrence Gibbs General Counsel Purchase of securities on an exchange or from another person at price $ 3.51 per share. 06 Jun 2017 1,000 10,431 (0%) 0% 3.5 3,510 Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.48 per share. 06 Jun 2017 3,000 4,667 (0%) 0% 0.5 1,440 Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2017 3,000 0 - - Stock Option (Right to Buy)
Rahul Dhanda SVP of Corporate Development Purchase of securities on an exchange or from another person at price $ 3.50 per share. 06 Jun 2017 1,000 5,667 (0%) 0% 3.5 3,500 Common Stock
Joanne Spadoro Chief Operations Officer Purchase of securities on an exchange or from another person at price $ 3.50 per share. 06 Jun 2017 5,000 5,589 (0%) 0% 3.5 17,500 Common Stock
David B. Elsbree None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2017 18,000 18,000 - - Restricted Stock Units
John W. Cumming None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2017 18,000 18,000 - - Restricted Stock Units
Seymour E. Liebman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2017 18,000 18,000 - - Restricted Stock Units
Stanley N. Lapidus None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2017 18,000 18,000 - - Restricted Stock Units
Michael J. Cima None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2017 18,000 18,000 - - Restricted Stock Units
Adrian M. Jones None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2017 18,000 4,175,240 (13%) 0% 0 Common Stock
Michael J. Cima None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 May 2017 1,400 184,418 (0%) 0% 0 Common Stock
Darlene M. Deptula-Hicks Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2017 175,000 175,000 - - Stock Option (Right to Buy)
David B. Elsbree None Purchase of securities on an exchange or from another person at price $ 5.97 per share. 15 Mar 2017 10,000 40,000 (0%) 0% 6.0 59,700 Common Stock
David P. Harding Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 17,500 17,500 - - Restricted Stock Units
David P. Harding Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 35,000 35,000 - - Stock Option (Right to Buy)
John McDonough Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 50,000 50,000 - - Restricted Stock Units
John McDonough Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 100,000 100,000 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 35,000 35,000 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 17,500 17,500 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 17,500 17,500 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 35,000 35,000 - - Stock Option (Right to Buy)
Rahul Dhanda SVP of Corporate Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 35,000 35,000 - - Stock Option (Right to Buy)
Rahul Dhanda SVP of Corporate Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 17,500 17,500 - - Restricted Stock Units
Shawn Lynch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 17,500 17,500 - - Restricted Stock Units
Shawn Lynch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 35,000 35,000 - - Stock Option (Right to Buy)
Joanne Spadoro Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 17,500 17,500 - - Restricted Stock Units
Joanne Spadoro Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2017 35,000 35,000 - - Stock Option (Right to Buy)
John McDonough Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2016 94,845 94,845 - - Restricted Stock Units
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2016 30,000 30,000 - - Restricted Stock Units
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2016 13,000 13,000 - - Restricted Stock Units
Rahul Dhanda SVP of Corporate Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2016 10,000 10,000 - - Restricted Stock Units
Seymour E. Liebman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Sep 2016 66,176 66,176 - - Stock Option (right to buy)
Joanne Spadoro Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Sep 2016 146,600 146,600 - - Stock Option (Right to Buy)
Rahul Dhanda SVP of Corporate Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Jun 2016 3,589 0 - - Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2016 3,589 3,589 - - Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2016 3,589 31,705 - - Stock Option (Right to Buy)
Stanley N. Lapidus None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 17,647 17,647 - - Stock Option (Right to Buy)
John W. Cumming None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 17,647 17,647 - - Stock Option (Right to Buy)
Harry W. Wilcox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 17,647 17,647 - - Stock Option (Right to Buy)
David B. Elsbree None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 17,647 17,647 - - Stock Option (Right to Buy)
Joshua H. Bilenker None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 17,647 17,647 - - Stock Option (Right to Buy)
Michael J. Cima None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2016 17,647 17,647 - - Stock Option (Right to Buy)
Shawn Lynch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2016 146,600 146,600 - - Stock Option (Right to Buy)
Rahul Dhanda SVP of Corporate Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Mar 2016 4,647 0 - - Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2016 4,647 4,647 - - Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2016 2,941 0 - - Stock Option (Right to Buy)
Rahul Dhanda SVP of Corporate Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Mar 2016 2,941 0 - - Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2016 4,647 0 - - Stock Option (Right to Buy)
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2016 2,941 2,941 - - Common Stock
Rahul Dhanda SVP of Corporate Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Mar 2016 13,770 0 - - Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2016 13,770 0 - - Stock Option (Right to Buy)
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2016 13,770 13,770 - - Common Stock
Rahul Dhanda SVP of Corporate Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Mar 2016 2,700 0 - - Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2016 2,700 2,700 - - Common Stock
Rahul Dhanda SVP of Corporate Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2016 2,700 13,770 - - Stock Option (Right to Buy)
Adrian M. Jones None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2016 66,176 66,176 - - Non-Qualified Stock Option (Right to Buy)
John McDonough Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2016 133,334 133,334 - - Stock Option (Right to Buy)
Sarah O. Kalil Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2016 40,000 40,000 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2016 58,800 58,800 - - Stock Option (Right to Buy)
Michael A. Pfaller Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2016 20,000 20,000 - - Stock Option (Right to Buy)
Michael Terrence Gibbs General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2016 60,000 60,000 - - Stock Option (Right to Buy)
Andrew N. Schiff Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Dec 2015 307,692 2,830,992 - - Common Stock
David B. Elsbree None Gift of securities by or to the insider at price $ 0.00 per share. 09 Dec 2015 22,222 27,778 - - Employee Stock Option (right to buy)
David B. Elsbree None Gift of securities by or to the insider at price $ 0.00 per share. 09 Dec 2015 7,189 8,987 - - Employee Stock Option (right to buy)
David B. Elsbree None Gift of securities by or to the insider at price $ 0.00 per share. 09 Dec 2015 5,882 11,765 - - Employee Stock Option (right to buy)
David B. Elsbree None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Dec 2015 10,000 30,000 - - Common Stock
Thomas J. Carella None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Dec 2015 700,000 4,157,240 - - Common Stock
David P. Harding Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Oct 2015 146,600 146,600 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 2,000 36,235 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 2,000 6,411 - - Common Stock
David B. Elsbree None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Aug 2015 75 4,275 - - Common Stock
Michael J. Cima None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Aug 2015 1,000 183,018 - - Common Stock
Maurice L. Castonguay Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2015 146,000 146,000 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2015 2,000 18,588 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2015 2,000 6,411 - - Common Stock
Thomas J. Lowery Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Jul 2015 2,000 4,411 - - Common Stock
Stanley N. Lapidus None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2015 17,647 17,647 - - Stock Option (Right to Buy)
John W. Cumming None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2015 17,647 17,647 - - Stock Option (Right to Buy)
Harry W. Wilcox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2015 17,647 0 - - Stock Option (Right to Buy)
David B. Elsbree None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2015 17,647 17,647 - - Stock Option (Right to Buy)
Thomas J. Carella None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2015 17,647 17,647 - - Stock Option (Right to Buy)
Joshua H. Bilenker None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2015 17,647 17,647 - - Stock Option (Right to Buy)
Michael J. Cima None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2015 17,647 17,647 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2015 1,000 18,647 - - Stock Option (Right to Buy)
Thomas J. Lowery Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2015 1,000 5,411 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters